0 Kommentare
0 Anteile
246 Ansichten
0 Vorschau
Search
Entdecken Sie neue Leute, neue Verbindungen zu schaffen und neue Freundschaften
-
Please log in to like, share and comment!
-
Hedgehog Pathway Inhibitor Drug Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Hedgehog Pathway Inhibitor Drug Market The global hedgehog pathway inhibitor drug market size was valued at USD 1.35 billion in 2025 and is expected to reach USD 3.24 billion by 2033, at a CAGR of 11.60% during the forecast period The reliable Hedgehog Pathway Inhibitor Drug...0 Kommentare 0 Anteile 190 Ansichten 0 Vorschau
-
HER2 Positive Breast Cancer Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period For structuring the finest market...0 Kommentare 0 Anteile 312 Ansichten 0 Vorschau
-
HER2 Positive Breast Cancer Treatment Market Growth, Targeted Oncology Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period Getting thoughtful about competitive...0 Kommentare 0 Anteile 221 Ansichten 0 Vorschau
-
HER2 Positive Breast Cancer Treatment Market Size, Targeted Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the HER2 Positive Breast Cancer Treatment Market The global HER2 Positive Breast Cancer Treatment market size was valued at USD 11.14 billion in 2025 and is expected to reach USD 12.54 billion by 2033, at a CAGR of 1.50% during the forecast period The HER2 Positive Breast Cancer...0 Kommentare 0 Anteile 294 Ansichten 0 Vorschau
-
HER2+ Gastric Cancer Market Advances with Targeted Therapy Innovations and Precision Oncology DevelopmentsAccording to the latest report published by Data Bridge Market Research, the HER2+ Gastric Cancer Market The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44% This global HER2+ Gastric Cancer Market report is a wonderful...0 Kommentare 0 Anteile 206 Ansichten 0 Vorschau
-
MET Inhibitor Drug Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the MET Inhibitor Drug Market The global MET Inhibitor Drug market size was valued at USD 1.89 billion in 2025 and is expected to reach USD 5.94 billion by 2033, at a CAGR of 15.40% during the forecast period This global MET Inhibitor Drug Market report is a wonderful guide to...0 Kommentare 0 Anteile 220 Ansichten 0 Vorschau
-
Vascular Endothelial Growth Factor VEGF Inhibitor Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Data Bridge Market Research analyses a growth rate in the vascular endothelial growth factor (VEGF) inhibitor market in the forecast period 2023-2030. The expected CAGR of vascular endothelial growth factor (VEGF) inhibitor market is tend to be...0 Kommentare 0 Anteile 201 Ansichten 0 Vorschau
-
Vascular Endothelial Growth Factor VEGF Inhibitor Market Size, Targeted Cancer Therapy Trends and Forecast" According to the latest report published by Data Bridge Market Research, the Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Data Bridge Market Research analyses a growth rate in the vascular endothelial growth factor (VEGF) inhibitor market in the forecast period 2023-2030. The expected CAGR of vascular endothelial growth factor (VEGF) inhibitor market is tend to be...0 Kommentare 0 Anteile 206 Ansichten 0 Vorschau
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Kommentare 0 Anteile 1KB Ansichten 0 Vorschau
-
Driving Growth & Opportunities in the Global Oncology Small Molecule Drugs Market Through 2031The Oncology Small Molecule Drugs Market is witnessing transformative growth as pharmaceutical innovation accelerates to address the global cancer burden. With therapeutics that can penetrate cellular targets, modulate intracellular pathways, and be administered orally, small molecule oncology drugs are becoming essential components of cancer treatment regimens worldwide. The Oncology Small...0 Kommentare 0 Anteile 1KB Ansichten 0 Vorschau
-
Global BRAF Kinase Inhibitors Market to Reach USD 3.78 Billion by 2034 Amid Rising Precision Oncology AdoptionAccording to a new report from Intel Market Research, the global BRAF kinase inhibitors market was valued at USD 1.85 billion in 2025 and is projected to reach USD 3.78 billion by 2034, growing at a CAGR of 7.5% during the forecast period (2026–2034). This growth trajectory reflects the expanding applications of BRAF inhibitors in precision oncology and the increasing prevalence of...0 Kommentare 0 Anteile 1KB Ansichten 0 Vorschau
-
Oncology Drugs Market to Reach USD 503.13 Billion by 2033, Growing at 11.6% CAGRMarket Overview The global oncology drugs market size was valued at USD 193.04 billion in 2024 and is projected to grow from USD 209.57 billion in 2025 to USD 503.13 billion by 2033, exhibiting a CAGR of 11.6% during the forecast period (2025-2033). The global Oncology Drugs market is witnessing swift transformation driven by new consumer behaviors, increased...0 Kommentare 0 Anteile 2KB Ansichten 0 Vorschau
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Kommentare 0 Anteile 1KB Ansichten 0 Vorschau
Suchergebnis
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek